Daniel Bode

Daniel Bode is a professional with extensive experience in the biotechnology and life sciences sectors, currently serving as an Associate at Angelini Ventures since September 2025. Previously, Bode held positions at Forbion as a Senior Analyst and Analyst, and at STRM.BIO as a Senior Business Development Associate and Program Lead. A Wellcome Trust PhD student in Stem Cell Biology at the University of Cambridge, Bode focused on protein and molecular networks in haematopoietic stem cell fate choices, earning a scholarship exceeding £185,000. Bode has also demonstrated leadership as Vice President and COO of the GapSummit 2018 and has contributed to several publications through research roles at the Wellcome Sanger Institute. Educational qualifications include a PhD and a Master of Research from the University of Cambridge, an MBA from Quantic School of Business and Technology, and a Bachelor's Degree in Biochemistry from the University of Dundee.